This message was sent to ##Email##
|Member Spotlight: AFMR Section Chairs
The four Regions of the AFMR (Western, Southern, Eastern and Midwestern) are represented by the following four Section Chairs who are also members of the AFMR National Council.
Philippe Montgrain, MD is an Associate Professor of Medicine at the VA San Diego Healthcare System and at UC San Diego Health Sciences. He completed his fellowship in Pulmonary and Critical Care Medicine as well as his residency in Internal Medicine at UC San Diego. He earned his medical degree from Indiana University. Dr. Montgrain is board certified in Pulmonary Medicine and Critical Care Medicine. His principal research interest is lung cancer with clinical interests including lung cancer screening, targeted therapy, and the timely diagnosis of lung cancer and delivery of lung cancer care. Specific interests include gender-based differences in lung cancer, tumor-microenvironment interactions, and biomarkers to predict response to therapy. His research has been supported by the NIH, the American Lung Association, and the VA Career Development Program. In addition to his role as Chair of the AFMR Western Section Council, Dr. Montgrain volunteers on the VA IRB and the VA Lung Cancer Care Collaborative, as well as serving as Chair of the Education Committee for the California Thoracic Society and as a member of the Planning Committee of the American Thoracic Society Assembly on Thoracic Oncology.
Philippe Montgrain, MD|
Chair, Western Section
Octavian C. Ioachimescu, MD, PhD is an Associate Professor of Medicine at Emory University and Atlanta VAMC, staff physician in Pulmonary, Critical Care and Sleep Medicine, where he serves as VA Sleep Medicine Section Chief and Medical Director of VA Sleep Medicine Center. Dr. Ioachimescu is the current Chair of the AFMR Southern Section, as well as serving as Chair of the Clinical Pulmonary Medicine Steering Committee and member of the Executive Committee of the Council of Networks of American College of Chest Physicians. At state level, he is the President of Georgia Association of Sleep Physicians (GASP).
Octavian C. Ioachimescu,|
Chair, AFMR Southern
Janice Dutcher, MD is the Associate Director of the Cancer Research Foundation of New York. She is board certified in internal medicine and medical oncology, received her medical degree from the University of California, Davis School of Medicine, completed residency training at Rush University Medical Center in Chicago, Illinois and completed her fellowship in oncology at the National Cancer Institute, Baltimore Cancer Research Program in Baltimore, Maryland. Dr. Dutcher has served as Professor of Medicine and Oncology at Albert Einstein College of Medicine and New York Medical College and has directed immunotherapy programs at Montefiore Medical Center, Our Lady of Mercy Medical Center, and St. Luke’s Roosevelt Hospital Center in New York, New York. She has participated in clinical trials of almost all of the new agents for RCC and Melanoma. In addition to her role as Chair of the AFMR Eastern Section, Dr. Dutcher is the immediate past chair of the Renal Cancer Subcommittee of the Eastern Cooperative Oncology Group and a founding member of the Cytokine Working Group. She is currently the Medical Oncology co-chair of the NCI Renal Cancer Task Force. She has participated in and chaired the Oncology Drug Evaluation Committee of the FDA. Her vast knowledge has been shared in the medical research community, as author of more than 300 papers and reviews, as well as mentor of doctors and students in numerous research projects.
Janice P. Dutcher, MD|
Chair, Eastern Section
Suthat Liangpunsakul, MD, MPH is an Associate Professor of Medicine, Biochemistry and Molecular Biology, in the Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University. He has been involved with the AFMR and its activity since 2009 in many leadership capacities, currently as the Chair of the Midwestern Section Council and Primary Investigator for R-13 Grants. His research interest is related to the mechanism and the genetic predisposition of alcohol-induced liver disease and the study of non-invasive markers for excessive alcohol use. His work has been funded by the NIH, VA, and Department of Defense.
Chair, Midwestern Section
Do you know a current AFMR member who is active in the field and deserves to be recognized for their outstanding or groundbreaking work? Nominate your colleague to be featured in our Member Spotlight section of Insights! Submit their story to us at firstname.lastname@example.org for the opportunity to be in the spotlight and recognized worldwide!
The leadership of the AFMR encourages you to submit your abstracts and attend our 2017 Regional Meetings for a great networking opportunity. We look forward to seeing you there!
Armand A. Krikorian, MD, FACE
Western Medical Research Conference (WMRC)
*formerly the Western Regional Meeting
January 26-28, 2017 - Sunset Center | Carmel, CA
The WMRC Program Planning Committee invites you to submit your abstract! Review 2016 WRM published abstracts in the Journal of Investigative Medicine.
WMRC Submission Deadline: Friday, September 30, 2016 at 11:59 PM EST
Southern Regional Meeting (SRM)
February 11-13, 2017 - InterContinental Hotel | New Orleans, LA
Please note that the 2017 SRM will now be held February 11-13, 2017 (Saturday-Monday) instead of February 16-18. The SRM Program Planning Committee invites you to submit your abstract! Review 2016 SRM published abstracts in the Journal of Investigative Medicine.
SRM Submission Deadline: Friday, October 7, 2016 at 11:59 PM EST
Eastern Regional Meeting (ERM)
April 18, 2017 - Marriott Wardman Park | Washington, DC
The ERM Program Planning Committee invites you to submit your abstract! Review 2016 ERM published abstracts in the Journal of Investigative Medicine.
ERM Submission Deadline: Wednesday, November 30, 2016 at 11:59 PM EST
For more information please visit the AFMR website.
Review 2016 published abstracts in the Journal of Investigative Medicine:
The Journal of Investigative Medicine (JIM) showcases the latest basic, clinical and translational research in a multidisciplinary forum. It is unique by publishing biomedical advances, as well as changes affecting the clinical research community, including abstracts from the AFMR’s 4 Regional Meetings. This is consistent with AFMR’s mission to develop and mentor tomorrow’s leaders in medical research. JIM was introduced in 1997 and is currently published by BMJ, offering 8 issues per year.
We invite you to submit a manuscript! There are no page charges for AFMR members whose manuscripts are published in JIM. Not a member? Join AFMR and enjoy the many benefits that membership provides!
The AFMR has been invited to participate as a Guest Society at the American Society for Investigative Pathology (ASIP) meeting, Pathobiology for Investigators, Students, and Academicians (PISA) 2016: Breakthroughs in Biology: From Underlying Pathogenesis to Translational Medicine at the Houston Methodist Research Institute and the Houston Marriott Medical Center, October 20-22, 2016 in Houston, Texas.
PISA 2016 will present exciting and cutting-edge concepts in pathogenesis and translational medicine. Scientific sessions will focus on the fields of immunity/inflammation, mucosal pathobiology, cell-cell communications in cancer, and microbiome & disease. View the scientific program online!
Early Registration Deadline: September 29, 2016 – Register today!
This is a great opportunity that we look forward to being a part of! For further questions regarding PISA 2016 please contact the AFMR National Office. We hope to see you there!
- AFMR members receive a special Guest Society Member registration discount
- Registration includes meals (3 breakfasts, 2 lunches, Welcome Reception) and meeting materials
Armand A. Krikorian, MD, FACE
Mark E. Sobel, MD, PhD
ASIP Executive Officer
Association for Clinical and Translational Science
For the latest news and trends in grant submissions, follow the ACTS Grant Blog! A number of grant opportunities are presented each month. Find out what’s new this month!
University of Illinois at Chicago
The Center for Clinical and Translational Science (CCTS) announces the availability of pilot grant funding for AY 2016-2017.The goals of the CCTS Pilot Grant Program are:
This program focuses on clinical and translational research, and as such, all applications must involve human subjects, facilitate human subject investigations, establish infrastructure related to human subject investigation, or concern disease mechanisms with clear, near term implications for therapeutics or prevention. Pilot funding aims to support several aspects of the collaboration that will lead to a successful, extramurally funded research programs.
- To foster outstanding new clinical and translational research at UIC by supporting the development of preliminary data that can be used to launch new NIH or other externally-funded research proposals;
- To encourage interdisciplinary teams of investigators that spans across Colleges and campus to develop collaborations or new research avenues;
- To promote interactions between basic and clinical scientists; and
- To support research collaborations with community partners and organizations.
On Tuesday, September 20, FASEB will host an educational briefing on developmental biology research funded by the National Science Foundation (NSF). Developmental biology seeks to explore some of the most fundamental topics in the biological sciences, including the processes that give rise to complex tissues, organs, and structures and how some species have the extraordinary ability to regenerate. Basic research in this area funded by the NSF has broadened our understanding of the natural world and has enormous implications for areas such as regenerative medicine.
A federal prize competition launched today is calling for innovative ideas for rapid, point-of-care laboratory diagnostic tests to combat the development and spread of drug resistant bacteria, a rising public health threat. Antibiotic resistant bacteria cause at least 2 million infections and 23,000 deaths each year in the United States, according to the Centers for Disease Control and Prevention.
In August, the National Institutes of Health (NIH) sought input on proposed changes to its Guidelines for Human Stem Cell Research that would permit certain human-animal chimera research. NIH also sought feedback on a proposed steering committee to provide programmatic input and ensure compliance with NIH guidelines and policies on human-animal chimera research.
AFMR will sponsor 2 symposia at next year’s Experimental Biology meeting, to be held on Saturday, April 23, 2017 in Chicago, IL.
New Insights into Insulin Resistance-Molecular Mechanisms and Therapeutic Implications
Chairs - Sharma Prabhakar(pictured left), MD, MBA, FACP, FASN, and Meredith Hawkins, MD, MS
Small GTPases: Basic Science to Translational Research
Chairs - Yutong Zhao(pictured right), MD, PhD and Anna Birukova, MD
We look forward to seeing you there!
Save-the-Date: Join us for the 2017 Combined Annual Meeting of the CSCTR and MWAFMR, April 20-21, 2017 at the Mid-America Club in Chicago, IL.
AFMR gratefully acknowledges the generous support of the Central Society for Clinical and Translational Research for the 2016 combined annual meeting.
As you review your annual giving for the upcoming year, I would like to ask you to consider a gift to the American Federation for Medical Research. Your contribution will be used to support AFMR-sponsored activities and we need your support.
With your generous donation, we can continue to offer innovative programs to help our members advance their careers at government facilities; medical centers; universities and medical schools; research institutions; and private industry in all 50 states and throughout the world. The AFMR provides young and aspiring trainees with scholarships and travel grants to attend regional meetings offering them the opportunity to present their findings to their peers and receive the guidance of senior scientists. The AFMR also recognizes trainees with national awards, such as the Henry Christian awards, named after the founder of the organization, Dr. Henry Christian. The AFMR strives to foster the development of future generations of clinical scientists and investigators through its initiatives, while encouraging public, private, and governmental investment in the development of these individuals.
Contributions are tax-deductible. Whether you choose to contribute $50, $100, $250, or another amount, I urge you to participate. I also welcome your suggestions or ideas about other potential sponsors for our programs. Most importantly, we thank you if you made a donation in 2016.
Please click here if you would like to make an online donation in 2016.
Leticia M. Ryan, MD, MPH
Washington University School of Medicine via ScienceDaily
Zika virus is capable of infecting the eye, according to a new study. The study, in mice, helps explain why some people with Zika virus develop eye disease, and suggests that contact with infected eyes may play a role in spreading the disease.
The New England Journal of Medicine
From 2004 through 2014, we randomly assigned 408 patients, 10 to 65 years of age, with traumatic brain injury and refractory elevated intracranial pressure to undergo decompressive craniectomy or receive ongoing medical care. The primary outcome was the rating on the Extended Glasgow Outcome Scale (an 8-point scale, ranging from death to “upper good recovery” [no injury-related problems]) at 6 months.
Science Translational Medicine
Chronic myeloid leukemia is usually held up as the poster child for targeted therapy, given the success of imatinib and related compounds such as nilotinib in treating the disease. Unfortunately, even these drugs are not perfect because they do not eliminate cancer stem cells. As a result, patients have to remain on treatment indefinitely or else face a high likelihood of relapse.
Advisers to the U.S. Cancer Moonshot Initiative have produced a wide-ranging laundry list of research targets for the project — even as its funding remains uncertain.
The 10 recommendations released include the launch of a national clinical-trial network specifically targeted at therapies that harness the immune system, and the creation of a 3-D cancer atlas to catalogue how a tumor interacts with neighboring normal cells.
|Jan. 26-28, 2017
||Western Medical Research Conference
|Feb. 11-13, 2017
||Southern Regional Meeting
||New Orleans, LA
|April 18, 2017
||Eastern Regional Meeting
|April 18-21, 2017
||Translational Science 2017
|April 20-21, 2017
||2017 Combined Annual Meeting of CSCTR & MWAFMR
|April 22-26, 2017
|| Experimental Biology 2017
| || |
Connect with AFMR
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Natalie Thomas, Assistant Executive Editor, 469-420-2635 | Contribute news
Elizabeth Chouinard, AFMR Executive Director, 978-927-8330 | www.afmr.org
Elissa Klein, AFMR Associate Executive Director, 978-927-8330 | www.afmr.org
Nicole Pinkham, AFMR Administrator, 978-927-8330 | www.afmr.org
American Federation for Medical Research
500 Cummings Center, Suite 4550 | Beverly, MA 01915 | 978-927-8330 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063